Home › Peripheral Arterial Disease › Florida › Tampa
Peripheral Arterial Disease clinical trials in Tampa, FL
4 studies for Peripheral Arterial Disease are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
RecruitingPhase 3
- Tampa Cardiovascular Interventions and Research, Tampa
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Florida Kidney Specialists, Temple Terrace · 7 mi away
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Recruiting
- University of South Florida, Tampa
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RecruitingPhase 3
- Tampa General Hospital, Tampa
About Peripheral Arterial Disease
Peripheral arterial disease (PAD) happens when there is a narrowing of the blood vessels outside of your heart. Learn about symptoms and treatment.
More about Peripheral Arterial Disease on MedlinePlus
Peripheral Arterial Disease trials in other cities
- Chicago, IL9 studies
- Dallas, TX9 studies
- Cleveland, OH9 studies
- Boston, MA9 studies
- Houston, TX8 studies
- Gainesville, FL7 studies
- Omaha, NE7 studies
- Nashville, TN6 studies
- Aurora, CO6 studies
- Minneapolis, MN6 studies
- Miami, FL6 studies
- Norfolk, VA5 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer51 studies
- Breast Cancer43 studies
- Cancer (all types)39 studies
- Colorectal Cancer33 studies
- Metastatic Cancer29 studies
- Lung Cancer29 studies
- Acute Myeloid Leukemia29 studies
- Pancreatic Cancer26 studies
- Ovarian Cancer21 studies
- Myelodysplastic Syndromes19 studies
- Melanoma19 studies
- Heart Failure18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.